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abstract
PURPOSE To evaluate and report the frequency of changes in radiation therapy treatment plans after peer review
in a simulation review meeting once a week.
MATERIALS AND METHODS Between July 1 and August 31, 2016, the radiation plans of 116 patients were
discussed in departmental simulation review meetings. All plans were finalized by the primary radiation on-
cologist before presenting them in the meeting. A team of radiation oncologists reviewed each plan, and their
suggestions were documented as no change, major change, minor change, or missing contour. Changes were
further classified as changes in clinical target volume, treatment field, or dose. All recommendations were
stratified on the basis of treatment intent, site, and technique. Data were analyzed by Statistical Package for the
Social Sciences and are presented descriptively.
RESULTS Out of 116 plans, 26 (22.4%) were recommended for changes. Minor changes were suggested in 15
treatment plans (12.9%) and a major change in 10 (8.6%), and only one plan was suggested for missing
contour. The frequency of change recommendations was greater in radical radiation plans than in palliative
plans (92.3% v 7.7%). The head and neck was the most common treatment site recommended for any changes
(42.3%). Most of the changes were recommended in the technique planned with three-dimensional conformal
radiation therapy (50%). Clinical target volume (73.1%) was identified as the most frequent parameter sug-
gested for any change, followed by treatment field (19.2%) and dose (0.08%).
CONCLUSION Peer review is an important tool that can be used to overcome deficiencies in radiation treatment
plans, with a goal of improved and individualized patient care. Our study reports changes in up to a quarter of
radiotherapy plans.
J Global Oncol. © 2019 by American Society of Clinical Oncology
Licensed under the Creative Commons Attribution 4.0 License
INTRODUCTION
Ensuring a high level of clinical quality in the practice
of radiation oncology has become increasingly im-
portant. The advancing knowledge about diseases and
the increasing complexity of radiation planning and
delivery methods can make radiation therapy vulner-
able to errors.1 A considerable variation in target vol-
ume delineation among radiation oncologists may
occur, which can influence local tumor control and
can result in undesirable complications in patients.2
These differences exist despite adherence to well-
established organ dose criteria and uniform contour-
ing guidelines.3 Therefore, a process is required to
prevent inadequacies in contouring and radiation
treatment planning.
Quality assurance (QA) is a systematic way of de-
termining inadequacies in any process by meeting
a required set of specifications or expectations. A QA
program provides a unified set of quality indicators that
focus on machines, personnel, and patients to ensure
safe and effective use of radiation therapy.4 Peer re-
view is an important measure for QA in radiation
oncology.5 It has been defined as “the evaluation of
creative work or performance by other people in the
same field to enhance the quality of work or the
performance of colleagues.”6 A meta-analysis has
shown that an audit and feedback can be effective in
improving professional practice.7 However, there is
a dearth of quality data in this regard in the field of
radiation oncology, and guidelines regarding peer
review with specific recommendations are few.8
Recognizing the need for peer review in the radiation
therapy treatment planning process, a simulation re-
view meeting (SRM) was held once a week in the
radiation oncology department starting from 2006 to
December 2016. All patients for whom radiation
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the SRM after undergoing the initial planning processes of
contouring and field arrangements. The SRM included
a review of the planned treatment by all the radiation on-
cologists, and changes were recommended and made as
a result of peer review, with consensus. The objective of this
study was to evaluate whether peer review in weekly SRMs
influences the radiation therapy treatment planning
process.
MATERIALS AND METHODS
This study was conducted from July 1 to August 31, 2016,
after approval by the institutional ethical review committee.
Patients who were booked for external beam radiation
therapy and underwent simulation were discussed rou-
tinely in the weekly SRM of the radiation oncology section of
Aga Khan University (AKU) Hospital. All patients, regard-
less of intent of treatment or technique of delivering ra-
diotherapy, were included in the study. Before discussion
in the SRM, the contouring of target volume was completed
and approved by the primary consultant radiation oncol-
ogist. Each plan was reviewed by at least two or three
radiation oncologists. All modifications were categorized as
no change, minor change, major change, or missing
contour (Table 1). Each change was further classified as
change in clinical target volume (CTV), treatment field, or
dose. Modification frequency was analyzed chronologically
and by treatment intent, tumor site, and treatment tech-
nique. Intent of treatment was recorded as either curative or
palliative. Tumor sites included the brain, head and neck,
thorax, abdomen, pelvis, extremity, and others. Treatment
techniques were two dimensional, three-dimensional
conformal radiation therapy (3D-CRT), and intensity
modulated radiation therapy (IMRT). Data were analyzed
by Statistical Package for the Social Sciences version 23
(SPSS, Chicago, IL) and are presented descriptively.
RESULTS
The study was conducted for a period of 2 months, during
which the radiation treatment plans of 116 patients with
cancer were reviewed in the weekly SRM. Amedian of three
consultant radiation oncologists attended the SRM, with
a range of two to four, together with radiation oncology
residents and medical physicists.
Out of 116 patients, 96 (82.8%) were planned to be treated
with curative intent, and 20 (17.2%) were planned to be
treated with palliative intent. Head and neck (n = 47
[40.5%]) was the most common reviewed site, followed by
the thorax (n = 30 [25.9%]) and pelvis (n = 17 [14.7%]).
The most frequent technique used in treatment planning
was 3D-CRT, which was used in 71 cases (61.2%), fol-
lowed by IMRT (n = 30 [25.9%]). A total of 26 changes
(22.6%) were recommended in radiation treatment plans.
Minor changes were recommended in 15 reviewed cases
(12.9%), whereas amajor change was recommended in 10
cases (8.6%; Table 2). Most changes were suggested in
CTV (n = 19 [73.1%]), with the least changes suggested in
the prescribed dose (n = 2 [0.08%]). Additional classifi-
cation of changes with respect to CTV, treatment field, and
dose is presented in Fig 1.
Radical treatment plans were recommended for the ma-
jority of changes as compared with palliative plans, as
shown in Fig 2. Among all the treated sites, the most fre-
quent changes were suggested in head and neck tumors
(42.3%). The breakdown of change recommendations for
all the treated regions is presented in Fig 3. When cate-
gorized by radiation planning techniques, 3D-CRT con-
stituted the majority of the changes (50%), followed by
IMRT (38.5%). Technique-based recommendations for
change are displayed in Fig 4. There were no changes
recommended in the contour of organs at risk.
DISCUSSION
Radiation oncology involves complex sequential processes
of consultation, simulation, planning, and delivery of
treatment. With the involvement of so many personnel and
procedures, each stage is prone to mistakes, which may
have a negligible to profound effect on the quality of related
outcomes and may eventually compromise patient care.
Therefore, to manage these discrepancies, there has been
a desperate need for the implementation of a tool or in-
tervention to ensure that patients receive treatment with
minimum chances of error that is evidence based and
appropriate to their medical condition.9 It is imperative to
note that AKU is accredited by the Joint Commission In-
ternational as an academic medical center. The compli-
ance to rigorous standards of patient safety and quality of
health care is binding.10 Furthermore, accreditation plays
an integral role in establishing methods to evaluate com-
pliance with international standards.
QA aimed at improving outcomes and eliminating errors
plays a vital role in the field of radiation medicine. Its im-
portance in radiation oncology is even greater because of
the unique nature of the multiple phases involved. Quality
control indicators are established in an attempt to ensure
consistent, safe, and optimal delivery of radiation, meeting
the highest standards of care.5 Examples of such quality
indicators include review of treatment plans and port films
by physicians and physicists, chart rounds, and timeouts
before treatment delivery.11 The quality management
TABLE 1. Operational Definitions
Change
Category Definition








Changes made within treatment volumes, fields
4. Missing
contour
Treatment volume or organ at risk contour found
to be missing
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guidelines focusing on measuring the functional perfor-
mance of the radiotherapy equipment by measurable pa-
rameters have been provided by the American Association
of Physicists in Medicine.12-15 The American College of
Radiology, the American Society for Radiation Oncology,
and the European Society for Radiotherapy and Oncology
have also developed practical guidelines to ensure quality
control during radiation delivery.16,17
Peer review is a valuable tool that is central to QA programs
in health care. It is practiced widely among radiation on-
cologists and has several dimensions, including review of
treatment decision making, planning contours, and other
parameters including, but not limited to, prescribed dose,
target volumes, technique, and patient set-up.8 Cancer
Care Ontario defines peer review as the evaluation of the
components of a radiation treatment plan by a second
radiation oncologist.18 Peer review is generally the only
opportunity for radiation oncologists to evaluate each
other’s cases and radiation plans. The input of physicists
and radiation therapy technologists is highly valued,19 and
the Association of Physicists in Medicine has published
guidelines for a peer review process between two qualified
clinical radiation oncology physicists.20 Peer review gen-
erally leads to small but potentially significant develop-
ments in professional practice and health care outcomes.
The success of review and feedback seems to depend on
baseline performance and on how the feedback is
provided.21 This becomes more important in developing
countries, which may lack expertise.22
There are a number of different formats for conducting peer
review. Most centers use peer review in multidisciplinary
groups that may or may not have a site-specific focus. The
timing of peer review also varies among different centers,
with a majority performing peer review before the initiation
of treatment.23 The concept of site-specific multidisci-
plinary team meetings, in which physicians from different
specialties and other members of the health care team
discuss patients with upcoming decision points, is
emerging in our country.24 However, there is a lack of
TABLE 2. Frequencies of Treatment Intent, Tumor Sites, Treatment


















No change 90 (77.6)
Minor change 15 (12.9)
Major change 10 (8.6)
Missing contour 1 (0.9)
Abbreviations: 2D, two dimensional; 3D-CRT, three-dimensional






































FIG 1. Classification of changes. CTV, clinical target volume.
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evidence about formal radiation oncology–specific meet-
ings in Pakistan other than at AKU, where all radiation plans
are evaluated by a team of qualified and trainee radiation
oncologists.
The goal of highly conformal radiation techniques such as
3D-CRT and IMRT is to increase the likelihood of tumor
control by precisely shaping the dose distribution to the
target volume. The reliable delivery of high-quality therapy
poses a unique challenge. It is essential to account for all
possible sources of uncertainties in treatment planning if
we are to achieve this goal. It is the preliminary re-
sponsibility of the radiation oncologist during treatment
planning to precisely delineate the target volumes and
normal organs at risk. Inaccurate demarcation may lead to
a geographic miss of a high-risk region and hence, reduced
local control and poor survival.25 This also exposes the
surrounding normal tissues to excess doses of radiation
beyond their tolerance limits, resulting in higher toxicities.
This severity of toxicity warrants the use of precise tech-
niques of delivering radiation.26
It is not uncommon to have a disagreement among radi-
ation oncologists about the delineation of target structures,
which may invariably have an impact on disease-related
outcomes. Interobserver variability in target volumes for
cancer treatment with radiation therapy has been dem-
onstrated in multiple studies.27-29 Lee et al30 performed
a study in which they investigated interobserver variation
among five radiation oncologists. Each radiation oncologist
was asked to contour the prostate independently on axial
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FIG 3. Categorization of changes with respect to treatment site.
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interstitial needles. There were significant interobserver
differences in the defined prostate volume, which led to
significant differences in dosimetry. Similarly, Logue et al31
reported significant interphysician variability in producing
target volumes and radiation plans for conformal radio-
therapy. These skills are enhanced by knowledge about
regional anatomy and patterns of failure; above all, the
physician’s experience plays an important role in drawing
a CTV.32 There is a need to quantify disagreements, and
additional effort to increase interobserver agreement is
required.
Several techniques and procedures have been developed to
overcome this variation. Contrast agents and metallic
markers have been used commonly to demonstrate the
anatomy during simulation to precisely delineate the target
volume and to increase the probability of tumor control.33
Valicenti et al34 presented a study in which seven radiation
oncologists delineated the prostate in groups of patients with
and without contrast medium. The study concluded that the
use of urethral and bladder contrast improved the reliability
of localizing the prostate. We routinely use contrast media
and markers as per international recommendations.
Inconsistency in contouring seems to be greater when
planning for adjuvant radiation therapy in postoperative
cases. The introduction of standardized contouring pro-
tocols has led to uniformity in delineation patterns among
physicians. In a study by Mitchell et al,35 the radiation plans
of three patients who had undergone a prostatectomy were
contoured by six radiation oncologists before and after,
providing a contouring atlas. A significant reduction in
variability in target volume outlining was achieved by ad-
hering to an evidence-based contouring protocol. The
importance of such protocols has also been highlighted by
Goodman et al,36 who presented stepwise contouring
guidelines and an atlas for the delineation of CTV in the
postoperative irradiation of pancreatic cancers. These
guidelines have helped physicians better determine areas
at risk and minimize dose to normal structures. The
planning target volume accounts for the patient set-up error
and internal target motion but not for the interobserver
variation in defining the CTV.37
In our study, 26 plans out of 116 (22.6%) were recom-
mended for changes; this frequency of change is much
higher than that reported in contemporary literature.38-40 All
the recommendations, major or minor, were implemented
by the primary radiation oncologist before the radiation
treatment plan was delivered to the treatment unit. In 2015,
the American Society for Radiation Oncology conducted
a nationwide survey related to peer review. The results
showed that 83% of radiation oncologists were involved in
the process, and among those, 90% changed their radi-
ation plans because of peer review, with approximately 7%
to 10% of plans being changed.38 Boxer et al39 did a pro-
spective real-time audit of 208 patients from June 2007 to
June 2008. Eight patients out of the 208 (3.8%) had
a change in management strategy recommended.
Brundage et al40 documented the pretreatment peer review
of 3,052 treatment plans over a period of 8 years. Out of the
3,052 audited radiation plans, 124 (4.1%) were identified
as having errors in radiation planning or prescription.
Modifications were made in 98 plans (3.2%) before
commencing radiation. The remainder went unchanged
because there were slight deviations from usual practice
because of individual patient characteristics.
Delineation of target volume has been identified as themost
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FIG 4. Categorization of changes with respect to treatment technique. 2D, two dimensional; 3D-CRT, three-
dimensional conformal radiation therapy; IMRT, intensity modulated radiation therapy.
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study, CTV was changed in a total of 19 cases (16.4%),
which is consistent with the literature.39,41 In the audit
performed by Boxer et al,39 most of the changes were
suggested in target volume coverage (2.9%), as compared
with prescribed dose and fractionation schedule. With the
use of precise radiation delivery techniques, the chances of
marginally missing the target volume are enhanced.
Therefore, there is a need to delicately contour the volumes
when using highly conformal radiation techniques. A multi-
institutional study by Lo et al41 reported changes in 66.7%
of stereotactic body radiation therapy plans for lung cancer
after peer review. The authors of this study concluded that
inadequate target volume coverage was the main com-
pulsion behind any change recommendation. Our nascent
experience with IMRT has forced us to be extra cautious
during contouring and also to seek help from colleagues.
Although we most frequently use 3D-CRT in our center,
data show that IMRT plans resulted in the most changes in
CTV (ie, 10 out of 19).
Our study emphasizes the need for peer review and its
impact on the planning process, but several shortcomings
require additional attention. First, the sample size was too
small to draw any meaningful inferences. Second, we did
not compare the pre- and postreview changes in the target
volumes. It is the usual practice of our radiation oncologists
to make changes in the existing contours. This might be
helpful in preventing planning on the wrong target volume,
but it does not allow us to quantify the difference in the sizes
of altered volumes. Cardenas et al42 found that postreview
volumes were larger than the prereview ones. Third, in
many instances, after a thorough and detailed discussion in
SRM, the treatment strategy was completely changed and
the patient was referred to a service other than radiation
oncology. Therefore, we have routine discussions about the
need to give radiation and at which doses, and we make
required changes after a consensus is achieved; however,
documentation is lacking in this regard. Now, we have
started daily peer review meetings, and we plan to publish
results of daily peer meetings with an increased sample
size and the addition of new variables.
Peer review is one of the most effective ways of dealing with
routine but controversial patient-specific decisions in ra-
diation oncology. It provides an opportunity to standardize
clinical practice patterns and to develop uniform treatment
planning guidelines, with a goal of improved and in-
dividualized patient care. Our study has shown that up to
a quarter of contours may change with peer review. More
work is required in this area for better treatment plans,
especially in developing countries.
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